Skip to main content

Emergent BioSolutions produces new Ebola vaccine, teaming with NIH, GlaxoSmithKline – Baltimore Sun

By March 17, 2015News
emergent-biosolution-logo

emergent-biosolution-logo

At its growing East Baltimore facility, Emergent BioSolutions has produced a booster shot to go with a leading Ebola vaccine candidate, joining a competitive race to make a safe and effective tool to stop the spread of an outbreak that continues in West Africa and to prevent future outbreaks.

{iframe}http://www.baltimoresun.com/health/bs-bz-emergent-ebola-vaccine-20150316-story.html{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.